Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report

Abstract

BACKGROUND

The role of primary-level medical pharmacists in medical institutions in China is limited; therefore, it is necessary to explore the role of pharmacists in the process of drug treatment.

CASE SUMMARY

A Chinese pharmacist participated in the complete treatment of a patient with a duodenal ulcer. The rationale for drug treatment was evaluated, and adjustments were made to the antacid and anti-infective regimen, as well as the dose and frequency of administration. Body temperature, routine blood examination, and adverse drug reactions were strictly monitored. During treatment, the pharmacist recommended anti-infective therapy with ampicillin–sulbactam, which effectively controlled the infection. Additionally, the pharmacist suggested changing famotidine to lansoprazole for acid suppression and gastroprotective treatment, combined with Chinese patent medicine such as Kangfuxin Liquid. This is the first case report of a pharmacist in primary-level medical institutions adjusting drug use for patients with duodenal ulcer and pulmonary infection.

CONCLUSION

A pharmacist participated in the treatment process, provided individualized medication adjustment, and achieved good clinical results.

Keywords: Ampicillin–sulbactam; Famotidine; Lansoprazole; Kangfuxin Liquid; Chinese pharmacist; Case report

Core Tip: Duodenal ulcer is a common digestive disease in clinical practice. The main treatment methods are to heal the ulcer, prevent recurrence and avoid complications. For the first time, we report a case of pharmacist in a medical institution participating in the treatment process of a patient with duodenal ulcer and pulmonary infection. It is worth noting that the drug combined with Kangfuxin Liquid had a good effect, which reminds us that individualized treatment is necessary and combination with Kangfuxin Liquid is a valuable research direction.